IGFBP2 and cancer: Insulin-like growth factor binding protein 2 (IGFBP-2) is of particular interest as in vitro studies have shown that it has a proliferative effect in mammary and other tumor cell lines [8–10] and clinical studies have shown it to be a prognostic biomarker for many cancers [11].